These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 23464884
1. Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. Patidar A, Singh DK, Winocour P, Farrington K, Baydoun AR. Clin Sci (Lond); 2013 Sep; 125(5):237-45. PubMed ID: 23464884 [Abstract] [Full Text] [Related]
7. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP. Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342 [Abstract] [Full Text] [Related]
8. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG. Nephrol Dial Transplant; 2012 Feb; 27(2):727-33. PubMed ID: 21750158 [Abstract] [Full Text] [Related]
10. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Smith ER, Cai MM, McMahon LP, Pedagogos E, Toussaint ND, Brumby C, Holt SG. Nephrology (Carlton); 2013 Mar; 18(3):215-21. PubMed ID: 23231493 [Abstract] [Full Text] [Related]
15. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T. Am J Physiol Renal Physiol; 2014 Jun 15; 306(12):F1418-28. PubMed ID: 24808541 [Abstract] [Full Text] [Related]